Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Motorola Solutions Buys Twisted Pair Solutions

Motorola Solutions, Inc. (MSI: Quote) said Thursday that it has bought privately held software communications company Twisted Pair Solutions.

Terms of the deal were not disclosed.

Twisted Pair's WAVE software transforms smartphones, tablets and PCs into powerful, secure communication solutions that provide integrated voice, text messaging, location and presence in one application that serves global public and private sector customers. 

Twisted Pair's WAVE Desktop, Dispatch and Web applications provide customers choices in their dispatch communications and unify communications among teams of workers, whether in their office or mobile. The WAVE communications platform provides interoperability to extend land mobile radios, PBXs and other communication systems, allowing teams of employees, whether mobile or in their offices, to effectively communicate through voice, text and data - securely, reliably and in real time - regardless of network, carrier, protocol or device.

Twisted Pair will be integrated into Motorola Solutions' Government Solutions business.

Click here to receive FREE breaking news email alerts for Motorola Solutions Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.